KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Gross Profit (2016 - 2025)

Teladoc Health's Gross Profit history spans 12 years, with the latest figure at $733.6 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 1668.16% year-over-year to $733.6 million; the TTM value through Dec 2025 reached $2.3 billion, up 51.08%, while the annual FY2025 figure was $2.3 billion, 28.44% up from the prior year.
  • Gross Profit for Q4 2025 was $733.6 million at Teladoc Health, up from $439.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.0 billion in Q4 2023 and bottomed at $41.5 million in Q4 2024.
  • The 5-year median for Gross Profit is $456.2 million (2024), against an average of $511.6 million.
  • The largest annual shift saw Gross Profit crashed 95.91% in 2024 before it skyrocketed 1668.16% in 2025.
  • A 5-year view of Gross Profit shows it stood at $778.9 million in 2021, then grew by 23.97% to $965.7 million in 2022, then increased by 4.94% to $1.0 billion in 2023, then plummeted by 95.91% to $41.5 million in 2024, then surged by 1668.16% to $733.6 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Gross Profit are $733.6 million (Q4 2025), $439.3 million (Q3 2025), and $730.1 million (Q2 2025).